Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now?

2 days ago 4

Maham Fatima

Sun, May 17, 2026 astatine 11:49 PM CDT 2 min read

PepGen Inc. (NASDAQ:PEPG) is 1 of the best NASDAQ stocks nether $5 to bargain close now. On May 12, PepGen reported Q1 2026 fiscal results, signaling a nett nonaccomplishment of $17.8 million, oregon $0.26 per share, compared to a nett nonaccomplishment of $30.2 cardinal for Q1 2025. R&D expenses decreased to $13.0 million, down from $25.4 cardinal successful the anterior year’s Q1, portion G&A expenses held dependable astatine $5.9 million. The institution concluded the 4th with $132.3 cardinal successful cash, currency equivalents, and marketable securities, which it expects volition supply a capable superior runway to money operations into H2 2027.

On the objective front, PepGen achieved afloat enrollment for the 10 mg/kg cohort of its Phase 2 FREEDOM2-DM1 aggregate ascending dose proceedings for PGN-EDODM1, an investigational oligonucleotide therapy for myotonic dystrophy benignant 1. Topline results from the archetypal 5 mg/kg cohort showed a favorable information illustration alongside promising splicing and objective data, supporting ongoing dose escalation. Data from the 10 mg/kg cohort remains connected way for merchandise successful H2 2026, portion the consequent 12.5 mg/kg cohort information is anticipated successful 2027.

Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now?

Regulatory expansions proceed with clearance to initiate the FREEDOM2 proceedings successful South Korea, Australia, and New Zealand, alongside progressive objective sites successful Canada and the UK. Meanwhile, the US FDA placed a partial objective clasp connected the survey regarding humanities preclinical pharmacology and toxicology data. PepGen Inc. (NASDAQ:PEPG) is moving to resoluteness the agency’s inquiries and noted that the timeline for the ongoing objective survey has not been impacted.

PepGen Inc. (NASDAQ:PEPG) is simply a clinical-stage biotech institution utilizing its proprietary Enhanced Delivery Oligonucleotide/EDO level to make therapies for terrible neuromuscular and neurological diseases. By utilizing cell-penetrating peptides to amended therapeutic uptake, the institution aims to people the basal causes of these superior conditions.

While we admit the imaginable of PEPG arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article